Axon Enterprise, Inc.

(NASDAQ Global Select)
Back to all articles
Bullish +70

Axon Enterprise: Impressive Growth, Real Margin Work Left

AI-generated analysis

- πŸ“‰ Axon Enterprise shares have dropped by half from their summer peak above $800 but have since remained flat since autumn 2024.

- πŸ’΅ Sales growth remains robust at 33% for 2025 with guidance indicating continued top-line momentum of 27-30% for 2026.

- πŸ“ˆ Long-term visibility is strong with revenue guidance reaching $6 billion by 2028.

- πŸ’Έ Profitability is constrained by high stock-based compensation that is expected to decline only marginally next year.

- βš–οΈ Operating leverage remains modest despite the significant pullback in share price from recent highs.

- πŸ“Š Valuation is considered demanding, trading at 9–10x forward sales with minimal real profits currently being realized.

- πŸ’‘ Immediate investment appeal is limited by these high multiples and slow margin expansion even with strong revenue potential.

Bullish Signals
  • Despite shares halving from their peak, Axon Enterprise maintains robust sales growth with revenue up 33% in 2025.
  • The company provides forward guidance for 27-30% revenue growth in 2026, indicating continued topline momentum.
  • Long-term visibility is strong, with a specific guidance target of $6 billion in revenue by 2028.
Risk Factors
  • Axon Enterprise shares have lost half their value from a peak of over $800, indicating significant recent capital erosion.
  • Profitability remains constrained by high stock-based compensation that is only marginally declining next year, limiting margin expansion despite revenue growth.
  • Valuation demands remain elevated at 9–10x forward sales with minimal real profits and modest operating leverage even after the pullback from highs.
  • Immediate investment appeal is limited by high multiples and slow margin expansion, offsetting strong long-term revenue visibility guidance of $6 billion for 2028.
Full Analysis
Axon Enterprise, Inc. (AXON) has experienced a significant decline in its share price, losing half of its value from a peak above the $800 mark during the summer prior to April 2026. Despite this correction and relatively flat returns since early autumn 2024, the company continues to demonstrate robust top-line performance with sales growth accelerating to 33% in 2025 and guidance ranging from 27% to 30% for 2026. The company maintains strong long-term growth visibility, having issued revenue guidance of $6 billion for 2028, driven by continued momentum in bookings and revenue expansion. However, profitability remains a key constraint on the stock's valuation due to persistently high stock-based compensation expenses, which are projected to decline only marginally in the near term. This structure has resulted in minimal real profits and modest operating leverage, even after the substantial pullback in share price. Consequently, the market currently values Axon at demanding multiples of 9–10x forward sales, reflecting skepticism over immediate investment appeal despite the underlying revenue growth story. The author notes that while long-term growth visibility is strong, the combination of high valuations and slow margin expansion limits the stock's attractiveness in the short term. The article emphasizes that investors must weigh impressive sales momentum against the challenge of translating that growth into profitable earnings, as margin work remains unfinished due to the heavy non-cash compensation costs. Seeking Alpha disclosures clarify that the author holds no positions in the company and the views expressed are their own opinions without external compensation.